(I) inside information; (ii) possible delay in publication of the annual results for the year ended 30 June 2026; and (iii) possible suspension of trading
Filed with HKEX · Stock code 660 · · 2 pages · English
(Incorporated in the Cayman Islands with limited liability) (Stock Code: 660) (I) INSIDE INFORMATION; (II) POSSIBLE DELAY IN PUBLICATION OF THE ANNUAL RESULTS FOR THE YEAR ENDED 30 JUNE 2026; AND (III) POSSIBLE SUSPENSION OF TRADING This announcement is made by the board of directors (the “Board”) of Wai Chun Bio-Technology Limited (the “Company”, together with its subsidiary, collectively referre
Wai Chun Bio-Technology Ltd. on 6ix
Earlier from Wai Chun Bio-Technology
- Resignation of chief financial officer, company secretary and authorised representative
- Appointment of chief financial officer, company secretary and authorised representative
- Resingation of chief financial officcer, company secretary and authorised representative
- 2020 Annual results announcement
- Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 March 2021
Later from Wai Chun Bio-Technology
- (I) delay in publication of the 2026 annual results; (ii) possible delay in despatch of the 2026 annual report; and (iii) suspension of trading
- Exchange notice - suspension of trading
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Supplemental announcement (i) delay in publication of the 2026 annual results; and (ii) continued suspension of trading
Follow Wai Chun Bio-Technology into a list and get an email when it puts out news.
Follow Wai Chun Bio-Technology